📰 Newspapers

FDA's long-term vacancy

FDA's long-term vacancy

Heidi Overton’s pulled nomination sets up a long-term vacancy.

The News

The leadership vacuum at the FDA won’t be filled anytime soon.

The White House’s last-minute decision to pull the nomination of Heidi Overton leaves the chances of Congress acting during the lame duck around zero, with the Senate health committee’s chair Bill Cassidy, R-La., predicting the job will “fall to the Senate Democrats.” The White House has a slim chance of finding a nominee who supports President Donald Trump’s health agenda and who could win support from the new Senate majority.

Former FDA officials told me they expect a string of acting commissioners to fill in for the next two years. One potential temporary leader is Sara Brenner, who held the acting title in early 2025 before departing the agency earlier this year to work as a senior counselor for public health at HHS. Another name being floated is Karim Mikhail, the FDA’s top regulator of vaccines and biologics.

The leadership void arrives as Congress takes up industry user fees, a critical source of about half of FDA’s funding. They require approval every five years.

Lawmakers could attach agency reforms to the package. FDA leaders have urged Congress to empower regulators with new authorities to mandate drug recalls and compel drugmakers to share data on their supply chains.

In brief

The News The leadership vacuum at the FDA won’t be filled anytime soon. The White House’s last-minute decision to pull the nomination of Heidi Overton leaves the chances of Congress acting during the lame duck around zero, with the Senate health committee’s chair Bill Cassidy, R-La., predicting the job will “fall to the Senate Democrats.

This is the opening of the story, shared with credit to Semafor. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at Semafor ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.